Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pratima Jain

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|May 29, 2007
ADHD: from childhood to adulthoodPratima Jain
Peerj. Computer Science|January 3, 2022
Frameworks for developing an Agro-Prosumer Community Group platformPratima Jain, Vidyasagr Potdar
Lancet (London, England)|February 27, 2007
Dental caries and social deprivationPratima Jain, Anandagiri Shankar, Sam Ramaiah
Current Drug Targets|March 17, 2012
Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitorRitesh Agrawal, Pratima Jain, S N Dikshit
Current Drug Targets|January 19, 2012
Apixaban: a new player in the anticoagulant classRitesh Agrawal, Pratima Jain, S N Dikshit
Combinatorial Chemistry & High Throughput Screening|November 13, 2012
Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agentsRitesh Agrawal, Pratima Jain, Subodh Narayan Dikshit
Protein and Peptide Letters|April 24, 2013
3D QSAR and docking studies of various amido and benzyl-substituted 3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl analogs as DPP-IV inhibitorsRitesh Agrawal, Pratima Jain, Subodh Narayan Dikshit, et al.
Combinatorial Chemistry & High Throughput Screening|January 12, 2013
3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitorsRitesh Agrawal, Pratima Jain, Subodh Narayan Dikshit, et al.
Mini Reviews in Medicinal Chemistry|April 20, 2012
Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptinRitesh Agrawal, Radhe Shyam Bahare, Pratima Jain, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|May 29, 2007
ADHD: from childhood to adulthoodPratima Jain
Peerj. Computer Science|January 3, 2022
Frameworks for developing an Agro-Prosumer Community Group platformPratima Jain, Vidyasagr Potdar
Lancet (London, England)|February 27, 2007
Dental caries and social deprivationPratima Jain, Anandagiri Shankar, Sam Ramaiah
Current Drug Targets|March 17, 2012
Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitorRitesh Agrawal, Pratima Jain, S N Dikshit
Current Drug Targets|January 19, 2012
Apixaban: a new player in the anticoagulant classRitesh Agrawal, Pratima Jain, S N Dikshit
Combinatorial Chemistry & High Throughput Screening|November 13, 2012
Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agentsRitesh Agrawal, Pratima Jain, Subodh Narayan Dikshit
Protein and Peptide Letters|April 24, 2013
3D QSAR and docking studies of various amido and benzyl-substituted 3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl analogs as DPP-IV inhibitorsRitesh Agrawal, Pratima Jain, Subodh Narayan Dikshit, et al.
Combinatorial Chemistry & High Throughput Screening|January 12, 2013
3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitorsRitesh Agrawal, Pratima Jain, Subodh Narayan Dikshit, et al.
Mini Reviews in Medicinal Chemistry|April 20, 2012
Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptinRitesh Agrawal, Radhe Shyam Bahare, Pratima Jain, et al.
Pageof 1